1.Wichers, MC, Kenis, G, Koch, GH, Robaegs, G, Nicolson, NA, Maes, M. Interferon apha induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res 2007;62:207–214.
2.A-M, Myint, Leonard, BE, Steinbusch, H, Y-K, Kim. Th1, Th2 and Th3 cytokine alterations in major depression. J Affect Dis 2005;88:169–173.
3.Minami, M, Kuraishi, Y, Yamaguchi, T, Nalai, S, Hirai, Y, Satoh, M.Immobilisation stress induces IL-1 beta nRNA in the rat hypothalamus. Neurosci Lett 1991;123:254–256.
4.Shintani, F, Nakaki, T, Kanba, S, Asai, M.Role of IL-1 in stress responses.A putative neurotransmitter. Mol Neurobiol 1995;10:47–71.
5.Persoons, JH, Schormagel, K, Breve, J, Berlkenbosch, F, Kraal, G.Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently. Am J Respir Crit Care Med 1995;152:619–624.
6.Zhou, D, Kusnecov, AW, Shurin, MR, De Paoli, M, Rabin, BS.Exposure to physical and psychological stressors elevates plasma IL-6: relationship to the activation of HPA axis. Endocrinol 1993;133:2523–2530.
7.Shizuya, K, Komori, T, Fujiwara, R, Miyahara, S, Ohmori, M, Nomura, J.Influence of restraint stress on the expression of mRNA for IL6 and IL-6 receptor in the hypothalamus and mid brain. Life Sci 1997;61:135–140.
8.Song, C, Leonard, BE.The olfactory bulbectomised rat model of depression. Neurosci Biobehav Rev 2005;29:627–647.
9.Maes, M. Major depression and activation of the inflammatory response. Adv Exp Biol Med 1999;461:25–46.
10.Holsboer, F. The rationale for CRH receptor antagonists to treat depression and anxiety. J Psychiat Res 1999;33:181–214.
11.Leonard, BE, A-M, Myint. Inflkammation and depression: is there a causal connection with dementia?. Neurotox Res 2006;10:149–160.
12.Geerlings, MI, Schoevers, RA, Beckman, AT.Depression and rik of cognitive decline and Alzheimer's disease. Results oftwo prospective community based studies in the Netherlands. Br J Psychiat 2000;176:568–575.
13.Chen, P, Ganguli, M, Mulsant, BH, DeKosky, ST.The temporal relationship between depressive symptoms and dementia. Arch Gen Psychiat 1999;56:261–266.
14.Nibuya, M, Takahashi, M, Russell, DS, Duman, RS.Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 1999;267:81–84.
15.A-M, Myint, Y-K, Kim. Cytokine-serotonin interaction through indoleamine dioxygenase: a neurodegenerative hypothesis of depression. Med Hypoth 2003;61:81–84.
16.Chiarrugi, A, Calvani, M, Meli, E, Traggiai, F.Synthesis and release of neurotoxic kynurenine metabolites by human monocyte derived macrophages. J Neuroimmunol 2001;120:190–198.
17.Guillemin, GJ, Smith, DG, Kerr, SJ, Smythe, GA, Kapoor, V, Armati, PJ. Characterisation of the kymurenine pathway metaboilism in human astrocytes and implications in neuro-pathogenesis. Redox Rep 2000;5:108–111.
18.Guillemin, GJ, Kerr, SJ, Smythe, GA, Smith, DG, Kapoor, V, Armali, PJ. Kynurenine pathway metabolism in human astro-cytes: a paradox for neuronal protection. J Neurochem 2001;78:842–853.
19.A-M, Myint, Y-K, Kim, Verkerk, R, Scharpe, S, Steinbusch, H, Leonard, BE.Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Dis 2007;98:143–151.
20.De La Garga, R. Endotoxin or proinflammatory cytokine induced sickness behaviour as an animal model of depression: focus on anhedonia. Neurosci Biobehav Rev 2005;29:761–770.
21.Leonard, BE. Inflammation.depression and dementia:are they connected? Neurochem Res 2007;32:1749–1756.